Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jun 30;20(6):e0325533. doi: 10.1371/journal.pone.0325533

Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties

Shafia Parveen 1, Shazia Iqbal 2, Saima Maher 1,*, Paul Wilson 3, Habib Nasir 4, Samreen Soomro 5, Shazia Nisar 6, Muhammad Imran 7, Musarat Riaz 1, Rabail Urooj 8, Mah Ganj Bakhshi 1, Maria Essa 1, Farah Mukhtar 1, Attya Bhatti 9, Hussnain A Janjua 10, Amir Faisal 11, Arsalan Saleem 12
Editor: Chinnaperumal Kamaraj13
PMCID: PMC12208411  PMID: 40587502

Abstract

This study investigated the green synthesis of silver nanoparticles (AgNPs) using the medicinal plant Asplenium dalhousiae focusing on its bioactive chemical constituents as natural reducing agents. Aqueous, chloroform, and n-hexane extracts of the plant leaves were utilized in the nanoparticle synthesis process. The synthesized AgNPs were confirmed through UV-visible spectroscopy, showing absorption peaks at approximately 420 nm, 443 nm, and 439 nm. Fourier-transform infrared (FTIR) spectroscopy was used to recognize the functional groups in the plant extracts responsible for facilitating the reduction process. The morphological and structural characteristics of the synthesized nanoparticles were analyzed using Scanning Electron Microscopy (SEM) and X-ray Diffraction (XRD). These analyses revealed that the nanoparticles synthesized using the Aqueous, chloroform, and n-hexane extracts were predominantly spherical silver nanoparticles (AgNPs) with a crystalline structure and an average diameter of 46.98 ± 12.45 nm, as determined by SEM. The antibacterial efficacy of the synthesized AgNPs was evaluated against Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa at a concentration of 30 μg/ml. Among the tested nanoparticles, the AgNPs synthesized from the n-hexane extract exhibited the highest antibacterial activity, with zones of inhibition measuring 20.0 ± 1.8 mm for E. coli, 19.0 ± 1.2 mm for B. subtilis, and 19.5 ± 1.4 mm for P. aeruginosa. Additionally, the silver nanoparticles (AgNPs) from Asplenium dalhousiae demonstrated significant α-amylase inhibition, with 85.04% inhibition at 500 µg/ml, compared to Acarbose (90.84%) and the leaf extract (78.65%). The antioxidant activity of the synthesized AgNPs was assessed using the DPPH method, which confirmed their significant antioxidant properties alongside their antibacterial activity. The aqueous and n-hexane silver nanoparticles (AgNPs) showed strong cytotoxic activity with low IC50 values, particularly in A2780 cells (15.76 µg/ml and 9.11 µg/ml, respectively), while the plant methanolic extract and CHCl3 AgNPs exhibited much higher IC50 values, indicating moderate to low activity. This study highlights the potential of AgNPs in handling anticancer, α-amylase, and antibacterial infections. By assimilating natural products with nanotechnology, it deals an inventive approach to developing targeted, eco-friendly therapies, paving the way for cutting-edge biomedical applications and improved treatment outcomes.

Introduction

Nanotechnology, a rapidly advancing interdisciplinary field including chemistry, biomedical science, material science, diagnostics, therapeutics, and medicine, comprises the production and application of nanoscale materials with various properties [1]. Its key significance is highlighted by its broad uses, predominantly catalyzing organic toxin reduction in environmental perceptions [24]. Furthermore, nanotechnologies have vital biological properties, such as anti-bacterial [5,6], Anti-oxidant [7,8], and anticancer activities [9]. Many inorganic metallic elements, comprising iron, copper, zinc, gold, silver, magnesium, and titanium, have been utilized in the biological, physical, and chemical synthesis of nanomaterials for a several determinations. Chemical methods are involved the use of harmful chemicals and energy intensive procedures, raising concerns about their environmental effect and the formation of toxic by-products. In compare, green synthesis methods deal a more sustainable resolution by utilizing bio-based materials, such as microorganisms, plants, as eco-friendly sources for nanoparticle synthesis. Many studies have confirmed that green synthesis not only reduces environmental harm but also effectively produces nanoparticles with desirable characteristics. Silver nanoparticles (AgNPs) play an important role in advanced research due to their nano medicinal prospective [10,11]. The green method in nanotechnology presents several advantages, encompassing cost-effectiveness, environmental affability, high yield, and precipitate synthesis [12]. In this method, the synthesis of silver nanoparticles (AgNPs) apply extracts from various plant parts [1317]. AgNPs are known for their biocompatibility and are important in the medical and pharmaceutical domains [18]. such as antibacterial activities [19,20], antioxidant qualities [21,22], immunological advantages [23], and anticancer activity, have been identified by researchers. Silver nanoparticles (AgNPs) have recently emerged as promising candidates for the development of novel anticancer drugs due to their broad spectrum of biological importance [911]. It exhibits potential cytotoxic effects on cancerous cells, which can be recognized to their exceptional physicochemical properties. The promising use of nanoparticles as therapeutic agents for focused cancer detection and controlling is rapidly gaining traction. Specially, AgNPs have concerned significant attention for their anticancer properties, comprising their capability to affect with signaling pathways dangerous for cancer cell growth and metastasis. literature suggest that AgNPs can induce cytotoxic effects on malignant cells, thereby inhibiting tumor growth and progression [24,25]. In addition to their anticancer potential, medicinal plants have long been recognized for their therapeutic benefits, particularly in regions like Pakistan, where traditional medicine relies heavily on plant-based remedies [26]. The adverse effects associated with synthetic pharmaceuticals, such as hypertension, hormonal imbalances, and weight gain, have further driven the resurgence in the use of natural products for medicinal purposes. A systematic investigation and further studies are required to recognize the mechanisms underlying these special effects and to confirm their efficacy with robust scientific confirmation [26]. A current study focused on the efficient exploration of Asplenium dalhousiae, a well-known medicinal plant. This research represents the first ever synthesis of silver nanoparticles using this plant species. The flowering period of Asplenium dalhousiae spans from July to December, thriving in moist environments typical of temperate and subtropical regions []. Compounds isolated from Asplenium dalhousiae comprise flavonoids, phenols, glycosides, alkaloids, coumarins, anthraquinones, quinones, cardiac glycosides, terpenoids, and saponins. The plant is particularly rich in phenolic and flavonoid as a major component, which contribute to its antioxidant activities [2631]. The study developed extracts from Asplenium dalhousiae to synthesize AgNPs and subsequently evaluated their antibacterial and antioxidant properties, α-amylase enzyme assay, Anticancer activity [3235]. Despite the plant’s recognized biological significance, its full potential remains underexplored. Previous reported data have proved its antibacterial and antifungal activities, as well as antifertility properties observed in adult male rats. A comprehensive investigation of Asplenium dalhousiae, aiming on its potential for silver nanoparticle (AgNP) synthesis and the bioactivities of these nanoparticles. While several studies have discovered plant mediated AgNP synthesis, comprising research on other Asplenium species, this is the first study to explore the use of Asplenium dalhousiae in this context. Additionally, our study is the first to assess the bioactivity of the AgNPs synthesized from Asplenium dalhousiae in terms of α-amylase inhibition and anticancer effects, specifically against colorectal (HCT116) and ovarian (A2780) cancer cell lines. Our findings contribute to the growing body of knowledge on plant mediated nanomaterials and highlight the new application of Asplenium dalhousiae for nanotechnology based therapeutic interventions.

Materials and methods

Sample collection, identification and analysis

The selected plant for this research, Asplenium dalhousiae, was collected from the Valley of Channat Bagh site in Azad Kashmir. Taxonomic identification was performed by Dr. Amir from NARC, Islamabad. The voucher specimen has been deposited in the Botany Department Herbarium under the code CHEM-311DX. The collected plant material was washed with distill water and then shade-drying, followed by uniform grinding the powder material was kept in refrigerator for further procedure.

Preparation of plant extracts (Asplenium dalhousiae)

The 500g of powdered dried plant material soaked in 100% methanol for 15 days at room temperature (approximately 25°C) [30]. The procedure was followed by filtration with help of 125 mm pore size Whatman filter paper. The filtrate was placed in rotatory evaporator to evaporate at 45°C [33]. The gummy crude extract was dissolved and suspended in distilled water (140 ml) and successively portioned with different organic solvent such as n-Hexane (3 × 200 ml), CHCl3 (3 × 200 ml) and a water layer (3 × 200 ml), (Fig 1).

Fig 1. Graphical abstract illustrating the green synthesis of silver nanoparticles (AgNPs) using Asplenium dalhousiae leaf extracts and their evaluation for antibacterial, antioxidant, α‐amylase inhibitory, and anticancer activities.

Fig 1

Synthesis of silver nanoparticle

1 mM silver nitrate solution and the plant aqueous, chloroform, and n-hexane extracts solution (1:1) were mixed on a hot plate with continuous stirring at 62°C and pH 11.72 until a color change indicated the synthesis of AgNPs [31]. The reaction progress was constantly monitored using a UV-visible spectrophotometer to record the SPR peak.

Characterization of silver nanoparticles

UV-Vis spectroscopy

UV-Vis spectroscopy plays an important role for examining the reduction of silver ions to silver nanoparticles. The UV spectra of Asplenium dalhousiae plant extract were taken at different concentrations the range was 250 mL to 650 mL in 10 mL AgNO3 solution. UV-2800, BMS model was used in this research. The spectra of AgNPs were recorded between 300 and 800 nm. The UV-Vis spectrum demonstrates the surface Plasmon resonance (SPR) absorption band of nanoparticles, showing a gradual decrease in absorbance with a shift in wavelength and changes in band width. This finding underscores the significance of the reduction of silver ions to silver nanoparticles and characterizing the silver optical properties of silver nanoparticles and structural features.

Fourier Transform Infrared (FTIR)

Fourier Transform Infrared (FTIR), is used to recognize the functional group existent in plant. This technique, highlighting the role of bioactive plants chemicals in reduction and capping processes. The IR spectra were recorded with support of Perklin Elmer spectrum 100 models.

X-ray diffraction

X-ray diffraction is a very advantageous technique to determine the crystalline nature structure and characterization of synthesized nanoparticles through X-ray diffractogram [36]. The instrumental model was used XRD; D8 Advance; Bruker, Billerica, MA, USA.

Scanning electron microscopy (SEM)

Scanning Electron Microscopy (SEM), the morphology and size of synthesized silver nanoparticles (Ag-NPs) were examined using the JEOL-6490A-JSM (SEM).

Energy dispersion X-ray (EDX)

Energy dispersion X-ray (EDX) was employed to acquire elemental composition of synthesized silver nanoparticles.

Preparation of Asplenium dalhousiae extract and AgNPs

The plant extracts were prepared using n-hexane, chloroform, and distilled water as solvents. For the green synthesis of silver nanoparticles (AgNPs), each dried extract (10 mg) was dissolved in 10 mL of sterile distilled water. A 1 mM aqueous solution of silver nitrate (AgNO₃) was then added to each plant extract solution to make a final reaction volume of 100 mL. The mixtures were incubated at room temperature, and the formation of AgNPs was indicated by a visible color change. The resulting solutions were then centrifuged at 4,000 rpm for 25 minutes to separate the synthesized silver nanoparticles. The supernatants were discarded, and the nanoparticle pellets were collected and stored for further characterization.

Antibacterial activity assay

The collected obtained pellets were used. The disc diffusion method was applied for antibacterial activity [22,34]. Amoxicillin+Clavuanic acid was used as standard solution. The nutrient agar was prepared by suspending 28.0 grams in 1000 ml of distilled water and sterilizing it by autoclaving at 15 Ibs pressure (121°C) for 15 minutes. The agar was then mixed well and poured into prepared sterile petri plates. Asplenium dalhousiae leaves extracts and its synthesized silver nanoparticles were studied [34]. The Gram-positive bacteria and Gram-negative bacteria strains were used in the biological assays. Nutrient agar was spread on sterilizes petri plates suspended in about 10 ml of physiological saline in a Roux bottle and was incubated at 37°C for 24 hours. The preparation of antibiotic sensitivity discs involves using Whatman No. 1 filter paper to create discs approximately 1 mm in diameter. These discs are then sterilized by placing them in hot air. After sterilization, each disc is loaded with 30 μl of the sample extract, silver nanoparticles (AgNPs), and a standard solution such as Amoxicillin+Clavuanic acid (30 mg/ml distilled water). Subsequently, the loaded discs are refrigerated for 24 hours before being used for experiments [35].

Microorganisms

The antimicrobial assay of Ag nanoparticles was examined against The following bacteria were tested the Gram-negative Escherichia coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853), as well as the Gram-positive Bacillus subtilis (ATCC 13048). Nutrient agar (NA) was used for bacterial growth. The agar plates were dried for 10 minutes. The selected bacterial strains were inoculated in nutrient broth to facilitate the growth of microorganisms.

Evaluation of anti-oxidant activity by DPPH assay

The antioxidant assay of plant three extracts a (n-hexane, chloroform and aqueous, extracts) and synthesized nanoparticles were evaluated by methanolic DPPH assay [37]. This assay is constructed on the reduction of a DPPH in the presence of a reducing agent or antioxidant, the result of this reaction is the development of a stable non-radical DPPH-H molecule. The AgNPs solution was prepared in methanol at different concentrations the range were 10–100 µg/ml, and 200µl from all dilution of silver nanoparticle solutions were added to 0.8 µl of DPPH solution. The samples were incubated in the dark for 30 minutes at room temperature, and the absorbance of each solution was read at 517 nm. Ascorbic acid was used as a positive control, and the antioxidant capacity to scavenge the DPPH radical was calculated as a percentage using the formula:

DPPH scavenging capacity (%) = [(A0  A1) / A0] × 100 

Where A0 is the absorbance of the control.

A1 is the absorbance of the sample [1].

In-vitro α-amylase enzyme assay

Alpha amylase inhibitors attach to the alpha bonds of polysaccharides like glycogen and starch, preventing their breakdown into glucose and maltose. These inhibitors play a vital role in several applications, and management human diseases. They work by reducing endogenous alpha amylase activity, thereby impeding the conversion of complex carbohydrates and disaccharides into absorbable monosaccharides. Clinical trials have shown that these inhibitors delay the digestion of complex carbohydrates and disaccharides, inhibiting α-glucosidases and impacting the absorption of glucose. Polyphenols found in dietary sources act as natural inhibitors of α-amylase and α-glucosidase, slowing down glucose absorption by interfering with these key enzymes involved in carbohydrate digestion. Numerous folkloric and medicinal plant extracts have demonstrated significant α-amylase inhibition activity, although additional animal studies are required to validate their hypoglycemic effects. Previous research has explored the role of medicinal plants in α-amylase enzyme inhibition such as, Prosopis cineraria (L.), Terfezia claveryi, Chenopodium album L., and Salvia lavandulifolia Vahl show the highest potential for α-amylase inhibition [32].

Anticancer activity

Anticancer activity states to the capability of a compound to inhibit the growth and propagation of cancer cells. To estimate this activity against colorectal (HCT116) and ovarian (A2780) cancer cell lines, the cancer cell lines (HCT116 and A2780) are cultured in media DMEM or RPMI-1640, added with 1% penicillin-streptomycin and 10% fetal bovine serum (FBS). The cells are kept in a moistened incubator at 36°C with 5% CO₂ [38]. The test components, silver nanoparticles (AgNPs), and plants extracts were dissolved in a DMSO solvent and diluted in the culture media to prepare different concentrations.

Cancer cells are placed into 96-well plates at a density of 5,000–10,000 cells per well and left overnight to attach to the surface. The cells are then treated with different concentrations of the test compound for 24, 48, and 72 hours. After treatment, cell viability is assessed using methods such as the MTT or CCK-8 assay. These assays measure metabolic activity by detecting color or fluorescence changes, which are proportional to the number of viable cells. Apoptosis is assessed using flow cytometry with annexin V-FITC and propidium iodide (PI) staining, while cell cycle analysis is performed by examining DNA content through PI staining. Morphological changes, such as cell shrinkage and chromatin condensation, are observed under a microscope to confirm apoptotic activity [39,40]. Results are expressed as IC₅₀ values, which indicate the concentration of the compound needed to inhibit 50% of cell growth. These values are statistically analyzed to compare treated cells with controls. Compounds demonstrating significant inhibition of cell growth, induction of apoptosis, or cell cycle stop against HCT116 and A2780 cell lines may have potential therapeutic implications for colorectal and ovarian cancer treatment [4144]. The statistical significance of these results was assessed using one-way ANOVA followed by Duncan’s multiple range test, as previously described by Harvey and Paige [45,37].

Statistical analysis

The statistical analysis involved expressing the results as Mean ± SD it is used to determine significant differences in each samples, a one-way analysis of variance (ANOVA) was conducted, followed by the Duncan’s test for multiple comparisons, as outlined by Harvey and Paige (1998) [45,37]. The statistical analysis was carried out using Graph Pad Prism Software, version 5. A significance level of p < 0.05 was considered, indicating that results with a p-value below this threshold were deemed statistically significant. This approach provided a comprehensive evaluation of the antibacterial activity of Ag-NPs and their effectiveness against different bacterial strains

Results

Synthesis of AgNPs

In the current study, (S1 Fig) the biosynthesis of silver nanoparticles (AgNPs) was conducted under laboratory conditions using Asplenium dalhousiae (S2 Fig) plant extract, with three different fractions. The synthesis of silver nanoparticles (AgNPs) was confirmed by a visible color change in the reaction medium from yellow to orange-brown.

UV-Vis spectroscopy

The green synthesis of silver nanoparticles using the plant extract of Asplenium dalhousiae resulted in a color change from pale yellow to orange-brown, representing the formation of silver nanoparticles the UV-Vis results showing absorption peaks at 423 nm (aqueous extract), (Fig 2a) 420 nm (chloroform extract), (Fig 2b) and 425 nm (n-hexane extract), (Fig 2c). These absorption peaks support with previous reported data [33], of silver nanoparticles at 400 nm. Particularly, the broadening of the peak detected in spectra of the n-hexane as the higher concentration of silver nanoparticles it was compared with the other two extracts.

Fig 2. UV-Vis spectra of Asplenium dalhousiae plant extract. a) aqueous b) chloroform c) n-hexane extracts.

Fig 2

Fourier transforms infrared spectroscopy

Fourier transformed infrared spectroscopy is used to identified the function group present in plant. It also very valuable to designates about molecular structure and type of chemical bonding which are responsible for the reduction of silver ion.

FT-IR study on plant extracts and AgNP samples indicate the presence of different functional groups in plant. The strong broad band around 3,400 cm−1 indicates the presence of alcoholic, phenolic, and carboxylic groups, predominantly O-H stretching of hydroxyl groups, N-H stretching vibrations of amines and amides, and water molecules [27]. The C-N stretching vibration of aromatic amines is seen at 1,145 cm−1, whereas the primary and secondary amines and amides are showed by bands between 900–600 cm−1. Ketones, aldehydes, quinines, and esters are suggested by peaks between 1,700 and 1,600 cm−1 (C = O vibration). Additionally, C-H stretching of alkanes is observed at 2,920 cm−1, C = C vibration of aromatic structures at 1,630 cm−1, and C-O stretching of phenolic groups at 1,245 cm−1 [39]. A broad band at 1,040 cm−1 indicates aromatic ethers and polysaccharides (C-O-C stretch). The FT-IR results shown in (Fig 3) confirm that the surface of AgNPs is covered by organic bioactive compounds consequent from the plant extracts Asplenium dalhousiae used in the study.

Fig 3. FTIR spectra of silver nanoparticles (AgNPs) synthesized using Asplenium dalhousiae extracts. a) AgNPs synthesized from aqueous extract, b) AgNPs synthesized from chloroform extract, and c) AgNPs synthesized from n-hexane extract.

Fig 3

XRD analysis

The X-ray diffraction (XRD) analysis of the synthesized silver nanoparticles (AgNPs) from Asplenium dalhousiae confirmed their crystalline nature, with sharp peaks observed at 2θ values of 37.93°, 45.5°, 64.40°, and 77.08° (Fig 4a4c). These peaks correspond to the (111), (200), (220), and (311) crystallographic planes of face-centered cubic (fcc) silver crystals, indicating a well-defined structure. Show in (Fig 4). The particle size was calculated to be approximately 20 nm using the Debye-Scherrer formula, which takes into account factors such as the X-ray wavelength, peak width, and Bragg angle. Notably, no impurities were identified in the sample, confirming the purity of the synthesized nanoparticles [41]. The data aligns with previous studies on silver nanoparticles, where similar 2θ values are associated with fcc silver structures. The sharpness of the peaks further supports the high crystallinity of the nanoparticles. The particle size of 20 nm falls within the typical range for biologically synthesized AgNPs, making them suitable for various applications such as antimicrobial agents or catalysts [36]. the study confirmed that the silver nanoparticles were well-defined and had a consistent diffraction profile across all samples.

Fig 4. XRD patterns of silver nanoparticles (AgNPs) synthesized using Asplenium dalhousiae plant extracts: a) aqueous extract, b) n-hexane extract, c) chloroform extract.

Fig 4

Scanning electron microscope (SEM)

The Scanning Electron Microscope (SEM) study of the synthesized silver nanoparticles consequent from plant extracts provided important insights into their morphology and structure. This high-resolution imaging technique allowed for the detailed examination of the nanoparticle surfaces, revealing their size, shape, and distribution [4042]. The AgNPs synthesized using the aqueous extract (Fig 5a), n-hexane extract (Fig 5b), and chloroform extract (Fig 5c) exhibited varying morphological characteristics as observed in the SEM images. Among these, the nanoparticles derived from the n-hexane extract (Fig 5b) showed with more uniform and well-dispersed spherical particles. The particle sizes ranged from 1–100 nm, with most particles appearing below 100 nm in diameter, predominantly spherical in shape across all extracts (Fig 5).

Fig 5. SEM images of silver nanoparticles (AgNPs) synthesized using Asplenium dalhousiae plant extracts: a) aqueous extract, b) n-hexane extract, c) chloroform extract.

Fig 5

Energy dispersive x-ray (EDX)

The EDX spectrum showed a strong peak corresponding to silver metal, confirming the presence of silver nanoparticles in the samples. The spectrum provided valuable information about the elemental composition of the nanoparticles, (Fig 6) which is vital for understanding their properties and potential applications [43,44,46,47]. EDX indicated the existence of silver (94%) and oxides, (6%) confirming the purity of nanoparticles, showed in (Fig 6a6c).

Fig 6. EDX spectra of silver nanoparticles (AgNPs) synthesized using Asplenium dalhousiae plant extracts: a) aqueous extract, b) chloroform extract, c) n-hexane extract.

Fig 6

Antibacterial activity of AgNPs

The antimicrobial activity of Asplenium dalhousiae different crude extract and synthesized AgNPs exhibited highest activity at the concentration of 30 μg/ml against three bacterial strains Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa. (S1 Table). The results, showed as the mean zone of inhibition (ZOI, mm) and standard deviation (SD), show distinctive differences in activity between the tested substances. Silver nitrate (AgNO3) exhibited moderate antimicrobial activity, (Fig 7) with inhibition zones ranging from 17.5 mm to 18.0 mm across the bacterial strains. (S1 Table). These results suggest that AgNO3 has some antimicrobial potential, though its efficacy is not as high as some of the other treatments (Table 1).

Fig 7. Graphical representation of DPPH, anti-bacterial, and anti-diabetic activity.

Fig 7

Table 1. Antibacterial activity of silver nanoparticles and plant extracts against selected bacterial.

Group Format Dose (µg/mL) E. coli (mm) B. subtilis (mm) P. aeruginosa (mm)
AgNO₃ 30 18.0 ± 1.2 17.5 ± 1.6 18.0 ± 1.2
AgNP of CHCl₃ extract 30 19.0 ± 1.2 18.0 ± 0.6 18.0 ± 1.4
AgNP Aqueous extract 30 19.5 ± 1.4 17.5 ± 1.6 17.0 ± 1.1
AgNP n-Hexane layer 30 20.0 ± 1.8 19.0 ± 1.2 19.5 ± 1.4
Plant extract of CHCl₃ extract 30 19.5 ± 1.0 17.0 ± 1.2 18.0 ± 1.2
Plant extract of Aqueous layer 30 16.0 ± 1.2 15.0 ± 1.6 16.5 ± 1.2
Plant extract of n-Hexane layer 30 17.0 ± 1.2 15.0 ± 0.6 15.0 ± 1.2
Standard (Amoxycillin) 30 23.0 ± 1.2 22.0 ± 1.2 23.0 ± 1.6

The was evaluated at a concentration of 30 µg/mL.

The mean zone of inhibition (ZOI, mm) ± standard deviation (SD) against Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa.

Silver nanoparticles derived from chloroform (CHCl3), aqueous, and n-hexane extracts all demonstrated enhanced antimicrobial activity compared to AgNO3. Show in (Fig 7a) Among these, AgNPs from the n-hexane exhibited the maximum zones of inhibition, with values ranging from 19.0 mm to 20.0 mm across the three bacterial strains. AgNPs from the CHCl3 extract showed inhibition zones of 18.0 mm to 19.0 mm, however AgNPs from the aqueous extract had slightly lower activity, with inhibition zones ranging from 17.0 mm to 19.5 mm. Plant extracts also showed variable degrees of antimicrobial activity. The CHCl3 extract showed the highest activity with inhibition zones ranging from 17.0 mm to 19.5 mm. The aqueous extract and n-hexane extract extracts demonstrated less activity, with inhibition zones ranging from 15.0 mm to 17.0 mm, representing a lower efficiency in comparison to both silver nanoparticles and the standard antibiotic. (Table 2). The silver nanoparticles (AgNPs) showed anti-bacterial efficiency against both Gram-positive and Gram-negative bacteria [38,48,49]. silver nanoparticles, particularly those derived from the n-hexane layer, showed the most potent antimicrobial activity, especially against E. coli [4244]. Plant extracts, while effective, exhibited relatively weaker activity compared to the silver nanoparticle formulations. Amoxicillin, as the standard antibiotic, demonstrated the highest inhibition ones, underscoring its broad-spectrum antimicrobial efficacy (Fig 7a).

Table 2. DPPH Radical scavenging capacity of ascorbic acid and (AgNPs).

Concentrations Ascorbic Acid (Mean ± SD) AgNPs Mean ± SD
10 45.69 ± 0.6 37.19 ± 1.2
20 52.54 ± 1.4 48.45 ± 1.6
40 64.27 ± 1.2 58.06 ± 1.8
60 90.77 ± 0.8 85.12 ± 1.6
80 110.06 ± 1.6 96.56 ± 1.2
100 108.77 ± 1.2 104.38 ± 1.8

2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical assay

The study demonstrates the significant antioxidant activity of Asplenium dalhousiae extracts, with the CHCl₃ crude extract exhibiting the highest DPPH radical scavenging activity due to its efficiency in extracting bioactive compounds. The variation in IC₅₀ values among solvent extracts highlights the critical role of solvent polarity in optimizing the extraction of antioxidant compounds (S2 Table). In contrast, the aqueous extract displayed lower activity, Additionally, silver nanoparticles (AgNPs) derived from the extracts exhibited notable biological activity, with an IC₅₀ value of 23.64 μg/ml, slightly higher than ascorbic acid (17.78 μg/ml), (Table 3) yet reflecting strong potency (Fig 7b). AgNPs demonstrated a dose-dependent increase in cell viability, reaching 96.56% at 80 μg/ml and exceeding 100% viability at higher concentrations, suggesting their biocompatibility and therapeutic potential. (Table 2). The comparative DPPH scavenging activity of AgNPs alongside crude extracts is essential for a comprehensive assessment of their antioxidant properties (Fig 7b). These findings underscore the therapeutic promise of Asplenium dalhousiae, the importance of solvent selection for bioactive compound extraction, and the enhanced biological potential of AgNPs as an antioxidant agent for therapeutic applications.

Table 3. DPPH radical scavenging capacities of ascorbic acid and AgNPs.

S. No Concentration (μg/ml) % Cell Viability
AgNPs Ascorbic Acid
1 10 37.19 ± 1.2 45.69 ± 1.2
2 20 48.45 ± 1.6 52.54 ± 1.6
3 40 58.06 ± 1.8 64.27 ± 1.8
4 60 85.12 ± 1.6 90.77 ± 1.6
5 80 96.56 ± 1.2 110.06 ± 1.2
6 100 104.38 ± 1.8 118.77 ± 1.8
IC50 (μg/ml) 23.64 17.78

Inhibition of in-vitro α-amylase enzyme assay

The hypoglycemic effects of Asplenium dalhousiae leaf extract and silver nanoparticles (AgNPs), (S3 Table) demonstrating a concentration dependent inhibition of α-amylase activity. (Fig 7c) At a concentration of 100 µg/ml, the inhibition percentages were 15.25% for the leaf extract, 18.58% for AgNPs, and 23.45% for Acarbose. (Table 4). With an increased concentration of 500 µg/ml, the inhibition percentages significantly rose to 78.65% for the leaf extract, 85.04% for AgNPs, and 90.84% for Acarbose [50]. The half-maximal inhibitory concentration (IC50) values for the α-amylase inhibition activity were calculated as 320.26 μg/ml for the leaf extract, 274.04 μg/ml for AgNPs, and 239.40 μg/ml for Acarbose. (Fig 7c) Notably, AgNPs exhibited a substantial in vitro antidiabetic effect against α-amylase activity, showing efficacy that was closer to the standard drug Acarbose than the crude leaf extract.

Table 4. Inhibition of in-vitro α-amylase enzyme assay.

Concentration (μg/ml) % Cell Viability
Asplenium dalhousiae Ag NPs Standard
100 15.25 ± 1.01 18.58 ± 1.30 23.45 ± 1.25
200 30.55 ± 1.50 38.5 ± 2.08 42.61 ± 2.45
300 44.16 ± 2.40 57.7 ± 3.09 65.74 ± 3.06
400 65.05 ± 3.01 71.44 ± 3.80 79.31 ± 3.70
500 78.65 ± 4.02 85.4 ± 4.09 90.84 ± 4.56
IC50 (μg/ml) 320.26 274.04 239.40

Anticancer activity

The AgNPs were tested for their anticancer activity against HCT116 and A2780 cell lines with the lowest IC50 concentration at 5, 10 and 30 μg/ml for various exposure times of 24, 48 and 72 h. Generally, green synthesized silver nanoparticles manifested the significant anticancer activity with toxic manner depending on the agents responsible for reducing and capping the silver nitrate into silver [38,51].

The Asplenium dalhousiae leaf extracts and silver nanoparticles (AgNPs) demonstrated significant inhibition of cell viability and proliferation in both A2780 and HCT116 cancer cell lines. The experimental results, analyzed using one-way ANOVA in the Origin program (version 8.5) and expressed as the mean ± standard deviation from three independent experiments, are presented in Table 5. At a concentration of 30 µg/ml, the inhibition against HCT116 cells was observed as follows: (Fig 8) the chloroform (CF) fraction showed 25.5% cell viability with an IC50 value of 50 ± 5 µg/ml, the hexane (HF) fraction showed 27.7% cell viability with an IC50 value of 45 ± 3 µg/ml, and the aqueous (AF) fraction showed 19.8% cell viability with an IC50 value of 40 ± 6 µg/ml. Similarly, in A2780 cells, the respective cell viability percentages were 23.2% (CF), 25.3% (HF), and 18.5% (AF), with corresponding IC50 values of 45 ± 4 µg/ml, 42 ± 4 µg/ml, and 38 ± 2 µg/ml (Fig 8). These results suggest that all samples inhibited cell proliferation in both cell lines, with the AF fraction showing the lowest cell viability and the most potent inhibitory effect in both HCT116 and A2780 cells, as indicated by the lower IC50 values (Table 5). Compared to previously reported data, the IC50 values of our samples are competitive [52,53]. For instance, Asplenium extracts in earlier studies have reported IC50 values above 50 µg/ml for the inhibition of cancer cell lines [40], while AgNPs typically show IC50 values around 40–60 µg/ml in similar cell lines [41]. Our findings, particularly with the AF fraction (IC50 of 38 ± 2 µg/ml in A2780 cells), demonstrate a more potent anticancer effect, highlighting the promising potential of Asplenium dalhousiae and AgNPs in cancer therapy. These results align with the findings of [42], who also demonstrated potent anticancer activity in plant based nanoparticle formulations with IC50 values in the similar range.

Table 5. The anticancer activity of different samples against HCT116 and A2780 cancer cell line.

Sample I.D.
AgNPs
Standard Conc. (µg/ml) Inhibition against HCT116 Inhibition against A2780
Cell Viability (%) IC50 ± SD Cell Viability (%) IC50 ± SD
CF 30 25.5 ± 1.2 50 ± 5 23.2 45 ± 4
HF 30 27.7 ± 0.6 45 ± 3 25.3 42 ± 4
AF 30 19.8 ± 1.4 40 ± 6 18.5 38 ± 2

Fig 8. Graphical representation of the anticancer activity.

Fig 8

The combination of Asplenium dalhousiae leaf methanolic extracts and synthesized silver nanoparticles (AgNPs: aqueous, n-hexane, and CHCl3 fractions) exhibits varied apoptotic activity against ovarian and colorectal cancer cells. Among the tested samples, the aqueous AgNPs showed the highest potency with IC50 values of 21.11 µg/ml standard error of the mean 0.93 for HCT116 cells and 15.76 µg/ml (7.75) for A2780 cells. In compare, the CHCl3 AgNPs exhibited the lowest activity, with IC50 values of 605.2 µg/ml (258.3) for HCT116 cells and 247.66 µg/ml (188.64) for A2780 cells. The n-hexane fraction showed medium efficiency, with IC50 values of 45.98 µg/ml (29.56) and 9.11 µg/ml (2.55) for HCT116 and A2780 cells, respectively. (Table 6, S3 Fig). This values compared to previously reported studies, the aqueous and n-hexane fractions demonstrated superior cytotoxic activity, with IC50 values significantly lower than the 30 50 µg/ml range reported for similar nanoparticle formulations against ovarian cancer cells [43,44]. These findings highlight the enhanced efficacy of combining Asplenium dalhousiae extracts with AgNPs, likely due to bioactive compounds in the extracts synergizing with the nanoparticles to increase apoptotic activity. The results suggest a promising strategy for developing potent anticancer treatments.

Table 6. Asplenium dalhousiae AgNPs inhibition against HCT116 and A2780.

I.D No. IC50 in HCT116 (µg/ml) Sem Replicate IC50 in A2780 (µg/ml) Sem Replicate
AgNP’s aqueous 21.11 0.93 2 15.76 7.75 2
AgNP’s, n-hexane, 45.98 29.56 2 9.11 2.55 2
AgNP’s CHCl3 605.2 258.3 2 247.66 188.64 2
Plant methanolic Extract 603.25 45.35 2 34.97 27.38 2
Result Active

Discussion

Green synthesis methods, which rely on natural materials, significantly reduce the risk of producing toxic byproducts that may adversely affect human health and the environment [32,33]. This approach is favored for its unique advantages, including non-toxic nature, environmental friendliness, cost-effectiveness, and suitability for biomedical applications, along with unique optical, electrical, catalytic, and magnetic properties [53]. Silver nanoparticles, in particular, have found extensive use in food industries, agriculture, biomedical settings, and drug delivery [54]. This study presents the green synthesis of silver nanoparticles (AgNPs) using Asplenium dalhousiae leaf extract, which acts as both a reducing and stabilizing agent in the reaction with silver nitrate salt. This method is noted for its eco-friendly and non-toxic nature, diverging from more traditional chemical synthesis methods that often involve hazardous substances. The synthesized nanoparticles were confirmed to be of pure silver through UV-VIS observed peak at 423 nm (aqueous extract), (Fig 2a) 420 nm (chloroform extract), (Fig 2b) and 425 nm (n-hexane extract), (Fig 2c). Many studies have been revealed the use of different plant extracts, such as A. esculentus flowers, Euphorbia wallichii, were used to synthesize silver nanoparticles efficiently [34,35]. Overall, the green synthesis of silver nanoparticles from Asplenium dalhousiae extract showcases a promising method for producing nanoparticles at 423 nm (Fig 2) and EDX analyses, (Fig 5) with sizes ranging from 1 to 100 nm as shown by SEM analysis. (Fig 6). This size range is particularly relevant for biomedical applications [39,40], where smaller particles can exhibit unique properties beneficial for therapy and diagnostics [48,49]. The use of distilled water, n-Hexane, and Chloroform as solvents in the synthesis process was explored, aiming to understand the effect of different solvents on the properties of the synthesized nanoparticles. The significance of this approach lies in its contribution to the field of green nanotechnology, providing a sustainable method to produce nanoparticles that are potentially less harmful to the environment and living organisms. Asplenium dalhousiae leaf extract not only plays a critical role in the synthesis of AgNPs but also exhibits substantial antioxidant properties. This is demonstrated by its ability to scavenge DPPH radicals, a common assay used to measure antioxidant capacity. This antioxidant activity is significant as oxidative stress is a known contributor to various diseases, including cancer, and antioxidants can help mitigate these effects. (Fig 7) Furthermore, the study investigates into the biological activities of the Asplenium dalhousiae leaf extract and synthesized AgNPs, particularly focusing on their enzymatic inhibition and anticancer properties. The α-amylase inhibitory effect, which exhibits a concentration-dependent manner, highlights the potential therapeutic applications in managing conditions such as diabetes, where slowing down the breakdown of starch can be beneficial. (Fig 7c). The most striking finding of this research is the enhanced cytotoxic effect against human ovarian cancer cells when combining Asplenium dalhousiae leaf extract with synthesized AgNPs [46,47]. This suggests that specific compounds within the leaf extract may synergistically interact with the silver nanoparticles, enhancing their ability to target and kill cancer cells. This observation is crucial as it opens new avenues for cancer treatment, where the goal is to develop therapies that are not only effective but also selective, and minimizing harm to healthy cells. This study not only advances the field of green nanotechnology by demonstrating an eco-friendly synthesis of silver nanoparticles but also illustrates the multifaceted potential of Asplenium dalhousiae leaf extract in therapeutic applications, ranging from antioxidant and enzymatic inhibition to potent anticancer activities. The integration of plant extracts with nanotechnology, as shown in this study, could lead to the development of novel therapeutic agents that are both effective and environmentally sustainable. In comparison to traditional chemical synthesis methods that involve toxic chemicals [51], our eco-friendly approach using Asplenium dalhousiae leaf extract aligns with the findings of [52], who synthesized silver nanoparticles using plant extracts and demonstrated their reduced toxicity in vivo [42]. The α-amylase inhibitory effect, which exhibits a concentration dependent manner, highlights the potential therapeutic applications in managing conditions such as diabetes, our results, showing concentration dependent α-amylase inhibition, align with the findings of [50,51], who observed similar effects in [52]. This further supports the potential of plant-derived AgNPs for diabetes management. Asplenium dalhousiae leaf extract with synthesized AgNPs. The enhanced cytotoxicity observed against human ovarian cancer cells is consistent with previous studies by [5254], who reported similar findings with AgNPs synthesized. Our results further emphasize the synergistic potential of plant extract mediated nanoparticle synthesis in cancer therapy. This suggests that specific compounds within the leaf extract may synergistically interact with the silver nanoparticles, enhancing their ability to target and kill cancer cells. This study not only advances the field of green nanotechnology by demonstrating an eco-friendly synthesis of silver nanoparticles but also illustrates the multifaceted potential of Asplenium dalhousiae leaf extract in therapeutic applications, ranging from antioxidant and enzymatic inhibition to potent anticancer activities. The integration of plant extracts with nanotechnology in this study mirrors the approach [38], where plant based silver nanoparticles exhibited significant therapeutic potential. This highlights the growing interest in harnessing the combined power of natural products and nanotechnology for medical applications. The integration of plant extracts with nanotechnology, as shown in this study, could lead to the development of novel therapeutic agents that are both effective and environmentally sustainable.

Conclusion

This study highlights a green and eco-friendly method for synthesizing silver nanoparticles (AgNPs) using Asplenium dalhousiae leaf extract, which serves as both a reducing and stabilizing agent. The synthesized AgNPs were characterized using UV-VIS, EDX, and SEM analyses, confirming their purity and nanoscale size (1–100 nm). The findings demonstrate significant biomedical potential, including antioxidant, enzymatic inhibition, and anticancer activities. Notably, the synergistic interaction between the leaf extract and AgNPs exhibited enhanced cytotoxicity against human ovarian cancer cells. These results align with previous findings by [44,54], who reported the biomedical efficacy of plant-mediated AgNPs in cancer therapy. Future studies should focus on further elucidating the molecular mechanisms underlying the enhanced anticancer effects and expanding the application of this green synthesis approach to other therapeutic targets. This integration of nanotechnology and natural products offers a sustainable platform for developing novel therapeutic agents that are environmentally friendly and biocompatible.

Supporting information

S1 Fig. Graphical abstract.

(TIF)

pone.0325533.s001.tif (787.5KB, tif)
S2 Fig. Asplenium dalhousiae.

(TIF)

pone.0325533.s002.tif (1.7MB, tif)
S3 Fig. Graphical representation of the anticancer activity.

(TIF)

pone.0325533.s003.tif (262KB, tif)
S1 Table. Antibacterial activity of silver nanoparticles and plant extracts against selected bacterial raw data file.

(TIF)

pone.0325533.s004.tif (354.2KB, tif)
S2 Table. DPPH Radical scavenging capacity of ascorbic acid and (AgNPs).

(TIF)

pone.0325533.s005.tif (196.4KB, tif)
S3 Table. Inhibition of in-vitro α-amylase enzyme assay raw data file.

(TIF)

pone.0325533.s006.tif (262KB, tif)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rajasekharreddy P, Rani PU. Biofabrication of Ag nanoparticles using Sterculia foetida L. seed extract and their toxic potential against mosquito vectors and HeLa cancer cells. Mater Sci Eng C Mater Biol Appl. 2014;39:203–12. doi: 10.1016/j.msec.2014.03.003 [DOI] [PubMed] [Google Scholar]
  • 2.Pradhan N, Pal A, Pal T. Silver nanoparticle catalyzed reduction of aromatic nitro compounds. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2002;196(2–3):247–57. doi: 10.1016/s0927-7757(01)01040-8 [DOI] [Google Scholar]
  • 3.Patel AC, Li S, Wang C, Zhang W, Wei Y. Electrospinning of Porous Silica Nanofibers Containing Silver Nanoparticles for Catalytic Applications. Chem Mater. 2007;19(6):1231–8. doi: 10.1021/cm061331z [DOI] [Google Scholar]
  • 4.Veisi H, Moradi SB, Saljooqi A, Safarimehr P. Silver nanoparticle-decorated on tannic acid-modified magnetite nanoparticles (Fe3O4@TA/Ag) for highly active catalytic reduction of 4-nitrophenol, Rhodamine B and Methylene blue. Mater Sci Eng C Mater Biol Appl. 2019;100:445–52. doi: 10.1016/j.msec.2019.03.036 [DOI] [PubMed] [Google Scholar]
  • 5.Das G, Patra JK, Debnath T, Ansari A, Shin H-S. Investigation of antioxidant, antibacterial, antidiabetic, and cytotoxicity potential of silver nanoparticles synthesized using the outer peel extract of Ananas comosus (L.). PLoS One. 2019;14(8):e0220950. doi: 10.1371/journal.pone.0220950 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Patil MP, Singh RD, Koli PB, Patil KT, Jagdale BS, Tipare AR, et al. Antibacterial potential of silver nanoparticles synthesized using Madhuca longifolia flower extract as a green resource. Microb Pathog. 2018;121:184–9. doi: 10.1016/j.micpath.2018.05.040 [DOI] [PubMed] [Google Scholar]
  • 7.Tanase C, Berta L, Coman NA, Roșca I, Man A, Toma F, et al. Investigation of In Vitro Antioxidant and Antibacterial Potential of Silver Nanoparticles Obtained by Biosynthesis Using Beech Bark Extract. Antioxidants (Basel). 2019;8(10):459. doi: 10.3390/antiox8100459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chokshi K, Pancha I, Ghosh T, Paliwal C, Maurya R, Ghosh A, et al. Green synthesis, characterization and antioxidant potential of silver nanoparticles biosynthesized from de-oiled biomass of thermotolerant oleaginous microalgae Acutodesmus dimorphus. RSC Adv. 2016;6(76):72269–74. doi: 10.1039/c6ra15322d [DOI] [Google Scholar]
  • 9.Erdogan O, Abbak M, Demirbolat GM, Birtekocak F, Aksel M, Pasa S, et al. Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells. PLoS One. 2019;14(6):e0216496. doi: 10.1371/journal.pone.0216496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ahmad A, Wei Y, Ullah S, Shah SI, Nasir F, Shah A, et al. Synthesis of phytochemicals-stabilized gold nanoparticles and their biological activities against bacteria and Leishmania. Microb Pathog. 2017;110:304–12. doi: 10.1016/j.micpath.2017.07.009 [DOI] [PubMed] [Google Scholar]
  • 11.Kolya H, Maiti P, Pandey A, Tripathy T. Green synthesis of silver nanoparticles with antimicrobial and azo dye (Congo red) degradation properties using Amaranthus gangeticus Linn leaf extract. J Anal Sci Technol. 2015;6(1). doi: 10.1186/s40543-015-0074-1 [DOI] [Google Scholar]
  • 12.Shehzad A, Qureshi M, Jabeen S, Ahmad R, Alabdalall AH, Aljafary MA, et al. Synthesis, characterization and antibacterial activity of silver nanoparticles using Rhazya stricta. PeerJ. 2018;6:e6086. doi: 10.7717/peerj.6086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Li S, Shen Y, Xie A, Yu X, Qiu L, Zhang L, et al. Green synthesis of silver nanoparticles using Capsicum annuum L. extract. Green Chem. 2007;9(8):852. doi: 10.1039/b615357g [DOI] [Google Scholar]
  • 14.Hemmati S, Rashtiani A, Zangeneh MM, Mohammadi P, Zangeneh A, Veisi H. Green synthesis and characterization of silver nanoparticles using Fritillaria flower extract and their antibacterial activity against some human pathogens. Polyhedron. 2019;158:8–14. doi: 10.1016/j.poly.2018.10.049 [DOI] [Google Scholar]
  • 15.Bhagat M, Anand R, Datt R, Gupta V, Arya S. Green Synthesis of Silver Nanoparticles Using Aqueous Extract of Rosa brunonii Lindl and Their Morphological, Biological and Photocatalytic Characterizations. J Inorg Organomet Polym. 2019;29(3):1039–47. doi: 10.1007/s10904-018-0994-5 [DOI] [Google Scholar]
  • 16.Lengke MF, Fleet ME, Southam G. Biosynthesis of silver nanoparticles by filamentous cyanobacteria from a silver(I) nitrate complex. Langmuir. 2007;23(5):2694–9. doi: 10.1021/la0613124 [DOI] [PubMed] [Google Scholar]
  • 17.El-Rafie MH, Mohamed AA, Shaheen ThI, Hebeish A. Antimicrobial effect of silver nanoparticles produced by fungal process on cotton fabrics. Carbohydrate Polymers. 2010;80(3):779–82. doi: 10.1016/j.carbpol.2009.12.028 [DOI] [Google Scholar]
  • 18.Logeswari P, Silambarasan S, Abraham J. Synthesis of silver nanoparticles using plants extract and analysis of their antimicrobial property. Journal of Saudi Chemical Society. 2015;19(3):311–7. doi: 10.1016/j.jscs.2012.04.007 [DOI] [Google Scholar]
  • 19.Anbu P, Gopinath SCB, Yun HS, Lee C-G. Temperature-dependent green biosynthesis and characterization of silver nanoparticles using balloon flower plants and their antibacterial potential. Journal of Molecular Structure. 2019;1177:302–9. doi: 10.1016/j.molstruc.2018.09.075 [DOI] [Google Scholar]
  • 20.Anwar A, Perveen S, Ahmed S, Siddiqui R, Shah MR, Khan NA. Silver Nanoparticle Conjugation with Thiopyridine Exhibited Potent Antibacterial Activity Against Escherichia coli and Further Enhanced by Copper Capping. Jundishapur J Microbiol. 2019;In Press(In Press). doi: 10.5812/jjm.74455 [DOI] [Google Scholar]
  • 21.Yousaf A, Zafar A, Ali M, Bukhary SM, Manzoor Y, Tariq T, et al. Intrinsic Bio-Enhancer Entities of Fagonia cretica for Synthesis of Silver Nanoparticles Involves Anti-Urease, Anti-Oxidant and Anti-Tyosinase Activity. ABB. 2019;10(12):455–68. doi: 10.4236/abb.2019.1012032 [DOI] [Google Scholar]
  • 22.Mohanta YK, Biswas K, Panda SK, Bandyopadhyay J, De D, Jayabalan R, et al. Phyto-assisted synthesis of bio-functionalised silver nanoparticles and their potential anti-oxidant, anti-microbial and wound healing activities. IET Nanobiotechnol. 2017;11(8):1027–34. doi: 10.1049/iet-nbt.2017.0017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Daniel SCGK, Tharmaraj V, Sironmani TA, Pitchumani K. Toxicity and immunological activity of silver nanoparticles. Applied Clay Science. 2010;48(4):547–51. doi: 10.1016/j.clay.2010.03.001 [DOI] [Google Scholar]
  • 24.Zhang K, Liu X, Ravi SOAS, Ramachandran A, Ibrahim IA, Nassir AM, et al. Synthesis of silver nanoparticles (AgNPs) from leaf extract of Salvia miltiorrhiza and its anticancer potential in human prostate cancer LNCaP cell lines. Artificial Cells, Nanomedicine, and Biotechnology. 2019;47(1):2846–54. doi: 10.1080/21691401.2019.1638792 [DOI] [PubMed] [Google Scholar]
  • 25.Banerjee K, Das S, Choudhury P, Ghosh S, Baral R, Choudhuri SK. A Novel Approach of Synthesizing and Evaluating the Anticancer Potential of Silver Oxide Nanoparticles in vitro. Chemotherapy. 2017;62(5):279–89. doi: 10.1159/000453446 [DOI] [PubMed] [Google Scholar]
  • 26.Al-Assar NB, Khattak MNK, Mashwani Z-U-R, Kanan S, Ullah I, Ali U, et al. Phytochemical profile and antiproliferative activities of acetone extracts of Asplenium polypodioides Blume. and A. dalhousiae Hook. in MDA-MB-231 breast cancer cells. Saudi J Biol Sci. 2021;28(11):6324–31. doi: 10.1016/j.sjbs.2021.06.098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Thirumurugan G, Shaheedha SM, Dhanaraju MD. In vitro evaluation of antibacterial activity of silver nanoparticles synthesized by using Phytophthora infestans. International Journal of ChemTech Research. 2009;1(3):714–6. [Google Scholar]
  • 28.Bisht AS. Pharmacognostical and phytochemical evaluation of whole plant of Asplenium dalhousiae hook (fern). World Journal of Pharmaceutical Research. 2015;4(9):2186–91. [Google Scholar]
  • 29.Banerjee K, Das S, Choudhury P, Ghosh S, Baral R, Choudhuri SK. A Novel Approach of Synthesizing and Evaluating the Anticancer Potential of Silver Oxide Nanoparticles in vitro. Chemotherapy. 2017;62(5):279–89. doi: 10.1159/000453446 [DOI] [PubMed] [Google Scholar]
  • 30.Maher S, Zamina B, Riaz M, Riaz S, Khalid N, Imran M, et al. Green Synthesis of Withania coagulans Extract-Mediated Zinc Oxide Nanoparticles as Photocatalysts and Biological Agents. ACS Omega. 2023;8(49):46715–27. doi: 10.1021/acsomega.3c05947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hu G, Liang G, Zhang W, Jin W, Zhang Y, Chen Q, et al. Silver nanoparticles with low cytotoxicity: controlled synthesis and surface modification with histidine. J Mater Sci. 2018;53(7):4768–80. doi: 10.1007/s10853-017-1940-6 [DOI] [Google Scholar]
  • 32.Oboh G, Akinyemi AJ, Ademiluyi AO. Inhibition of α-amylase and α-glucosidase activities by ethanolic extract of Telfairia occidentalis (fluted pumpkin) leaf. Asian Pac J Trop Biomed. 2012;2(9):733–8. doi: 10.1016/S2221-1691(12)60219-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Nasir GA, Mohammed AK, Samir HF. Biosynthesis and characterization of silver nanoparticles using olive leaves extract and sorbitol. Iraqi Journal of Biotechnology. 2016;15(1):22–32. [Google Scholar]
  • 34.Devanesan S, AlSalhi MS. Green Synthesis of Silver Nanoparticles Using the Flower Extract of Abelmoschus esculentus for Cytotoxicity and Antimicrobial Studies. Int J Nanomedicine. 2021;16:3343–56. doi: 10.2147/IJN.S307676 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ghani S, Rafiee B, Bahrami S, Mokhtari A, Aghamiri S, Yarian F. Green Synthesis of Silver Nanoparticles Using the Plant Extracts of Vitex Agnus Castus L: An Ecofriendly Approach to Overcome Antibiotic Resistance. Int J Prev Med. 2022;13:133. doi: 10.4103/ijpvm.ijpvm_140_22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mehta BK, Chhajlani M, Shrivastava BD. Green synthesis of silver nanoparticles and their characterization by XRD. J Phys: Conf Ser. 2017;836:012050. doi: 10.1088/1742-6596/836/1/012050 [DOI] [Google Scholar]
  • 37.Wickramaratne MN, Gunatilake LP, Anuradha NGD, Godavillathanna AN, Perera MGN, Nicholas I. Antioxidant activity and antibacterial activity of Walidda antidysenterica. Journal of Pharmacognosy and Phytochemistry. 2015;4(2):121–6. [Google Scholar]
  • 38.Mittal AK, Tripathy D, Choudhary A, Aili PK, Chatterjee A, Singh IP, et al. Bio-synthesis of silver nanoparticles using Potentilla fulgens Wall. ex Hook. and its therapeutic evaluation as anticancer and antimicrobial agent. Mater Sci Eng C Mater Biol Appl. 2015;53:120–7. doi: 10.1016/j.msec.2015.04.038 [DOI] [PubMed] [Google Scholar]
  • 39.Banerjee P, Satapathy M, Mukhopahayay A, Das P. Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: synthesis, characterization, antimicrobial property and toxicity analysis. Bioresour Bioprocess. 2014;1(1). doi: 10.1186/s40643-014-0003-y [DOI] [Google Scholar]
  • 40.Zhang L, Liu R, Niu W. Phytochemical and antiproliferative activity of proso millet. PLoS One. 2014;9(8):e104058. doi: 10.1371/journal.pone.0104058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Erdogan O, Abbak M, Demirbolat GM, Birtekocak F, Aksel M, Pasa S, et al. Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells. PLoS One. 2019;14(6):e0216496. doi: 10.1371/journal.pone.0216496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Das G, Patra JK, Debnath T, Ansari A, Shin H-S. Investigation of antioxidant, antibacterial, antidiabetic, and cytotoxicity potential of silver nanoparticles synthesized using the outer peel extract of Ananas comosus (L.). PLoS One. 2019;14(8):e0220950. doi: 10.1371/journal.pone.0220950 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ganesan A, Kumar N G, Natarajan PM. Anticancer activity of silver nanoparticles synthesized from aqueous leaf extract of Solanum trilobatum (Purple fruit pea eggplant) on human oral cancer cells. J Herbmed Pharmacol. 2024;13(2):260–8. doi: 10.34172/jhp.2024.49325 [DOI] [Google Scholar]
  • 44.Shaaban MT, Mohamed BS, Zayed M, El-Sabbagh SM. Antibacterial, antibiofilm, and anticancer activity of silver-nanoparticles synthesized from the cell-filtrate of Streptomyces enissocaesilis. BMC Biotechnol. 2024;24(1):8. doi: 10.1186/s12896-024-00833-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Bewick V, Cheek L, Ball J. Statistics review 9: one-way analysis of variance. Crit Care. 2004;8(2):130–6. doi: 10.1186/cc2836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Albadawi EA, Musa ENA, Ghaban HM, Ebrahim NA, Albadrani MS, El-Tokhy AI. Eco-friendly green synthesis of silver nanoparticles from guajava leaves extract for controlling organophosphorus pesticides hazards, characterization, and in-vivo toxicity assessment. BMC Pharmacol Toxicol. 2024;25(1):98. doi: 10.1186/s40360-024-00826-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bhusal M, Pathak I, Bhadel A, Shrestha DK, Sharma KR. Synthesis of silver nanoparticles assisted by aqueous root and leaf extracts of Rhus chinensis Mill and its antibacterial activity. Heliyon. 2024;10(13):e33603. doi: 10.1016/j.heliyon.2024.e33603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Periasamy S, Jegadeesan U, Sundaramoorthi K, Rajeswari T, Tokala VNB, Bhattacharya S, et al. Comparative Analysis of Synthesis and Characterization of Silver Nanoparticles Extracted Using Leaf, Flower, and Bark of Hibiscus rosasinensis and Examine Its Antimicrobicidal Activity. Journal of Nanomaterials. 2022;2022(1). doi: 10.1155/2022/8123854 [DOI] [Google Scholar]
  • 49.Rahman MM, Islam MB, Biswas M, Khurshid Alam AHM. In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh. BMC Res Notes. 2015;8:621. doi: 10.1186/s13104-015-1618-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kashtoh H, Baek K-H. New Insights into the Latest Advancement in α-Amylase Inhibitors of Plant Origin with Anti-Diabetic Effects. Plants (Basel). 2023;12(16):2944. doi: 10.3390/plants12162944 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Abbasi S, İlhan A, Jabbari H, Javidzade P, Safari M, Abolhasani Zadeh F. Cytotoxicity evaluation of synthesized silver nanoparticles by a green method against ovarian cancer cell lines. Nanomedicines Research Journal. 2022;7(2):156–64. [Google Scholar]
  • 52.Hou T, Guo Y, Han W, Zhou Y, Netala VR, Li H, et al. Exploring the Biomedical Applications of Biosynthesized Silver Nanoparticles Using Perilla frutescens Flavonoid Extract: Antibacterial, Antioxidant, and Cell Toxicity Properties against Colon Cancer Cells. Molecules. 2023;28(17):6431. doi: 10.3390/molecules28176431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Muthu T, Adusumalli R, Vemuri SK, Indira Devi M, Pavan Kumar P, Banala RR, et al. Eco-biofabrication of silver nanoparticles from Azadirachta indica, Gymnema sylvestre, and Moringa oleifera for lung cancer treatment. J Egypt Natl Canc Inst. 2025;37(1):1. doi: 10.1186/s43046-024-00252-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Gurunathan S, Park JH, Han JW, Kim J-H. Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy. Int J Nanomedicine. 2015;10:4203–22. doi: 10.2147/IJN.S83953 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Chinnaperumal Kamaraj

Dear Dr. maher,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

I recommend that the authors make major revisions to address the comments raised by reviewers. The revised manuscript should be resubmitted for further evaluation. Please include a detailed response letter outlining how each of these comments has been addressed, along with any changes made to the manuscript.

Thank you for your submission.

==============================

Please submit your revised manuscript by Jan 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Chinnaperumal Kamaraj, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why.

3. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files. If additional details or access are needed, please contact me directly.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. Please ensure that you refer to Figures 1-8 in your text as, if accepted, production will need this reference to link the reader to the figure.

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables1-6 in your text; if accepted, production will need this reference to link the reader to the Table.

Additional Editor Comments:

I recommend that the authors make major revisions to address the comments raised by reviewers. The revised manuscript should be resubmitted for further evaluation. Please include a detailed response letter outlining how each of these comments has been addressed, along with any changes made to the manuscript.

Thank you for your submission

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: N/A

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: No

**********

Reviewer #1: This manuscript describes the effects of the AgNPs using Asplenium dalhousiae on their antibacterial, antioxidant, α-amylase inhibitory and cytotoxic activities.

General comments,

The manuscript's structure is poorly organized; the author should revise it.

The author should maintain the same font throughout the manuscript.

The author should compare their results with previous studies to provide context and validate their findings. Additionally, the discussion section needs improvement to offer a more comprehensive analysis and interpretation of the results.

For the antibacterial activity, it is insufficient for the author to work with a single concentration, as this does not provide a comprehensive assessment of the antibacterial properties. Multiple concentrations should be tested to better evaluate the activity.

The author has presented their results in Figures 1, 2, 3, etc., without citing the figure numbers in the text. The author should properly cite the figure numbers in accordance with the corresponding results for better clarity and alignment.

More detailed table and figure captions should be given for self-understood.

The resolution of the characterization figures for the AgNPs needs to be improved to enhance clarity and allow for better interpretation of the results.

Table 3, the author should include the standard deviation (SD) value for each AgNPs and ascorbic acid in the same column, rather than in a separate column

In Table 4, it is unclear why the author has provided a 'groups' column for the concentration. This should be clarified or revised for better understanding. And delete the empty box in the table.

In Table 5, instead of 'Active,' the author should mention the value of the IC50.

Detailed comments have been noted on the manuscript.

Reviewer #2: Manuscript ID: PONE-D-24-42400

Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties

This study explores the feasibility of green synthesis of AgNPs using plant extracts, with antibacterial, antioxidant, and cytotoxic activities from Asplenium dalhousiae plants. Although the study emphasizes the potential biological properties of Asplenium dalhousiae, but it does not adequately justify its selection over other well-established method for synthesis of AgNPs using plant extracts. Significant efforts are required to differentiate this work from the current published literature and to claim the novelty. In addition, two kind of manuscript file submitted in one file the first one and the second one which is the better version and the following correction are suggested for the second one.

In its present form, the manuscript is not recommended for publication unless the following issues are addressed:

1. The English language and grammar in the whole manuscript needs further improvement, particularly in sections such as Introduction, Materials and Methods.

2. The statements such as “paving the way for improved treatment outcomes in patients with ovarian cancer” mentioned in the end of the Abstract are speculative without preclinical or clinical validation. Cytotoxicity is an in-vitro property that does not equate with the therapeutic efficacy for in-vivo and should be compared with literature to substantiate differences.

3. Figures are poorly presented and should be arranged into collages for better readability and interpretation.

4. The study lacks mechanistic insights, such as identifying specific compounds in Asplenium dalhousiae responsible for nanoparticle synthesis and their specific role in reduction and stabilization.

5. The α-amylase inhibition and cytotoxic mechanisms are not explained well by authors.

6. The authors claim in the introduction section that the reported work is the "first comprehensive investigation" of Asplenium dalhousiae which is unsupported with the previously published and related research. Comparison with other studies on plant-mediated AgNP synthesis is required to highlight the novelty.

7. Characterization methods such as UV-Vis, FTIR, XRD, and SEM are discussed generally, without any specific experimental optimization or justifications, that could be associated with the changes made before and after synthesis in the results obtained through these characterizations.

8. Statistical analysis is missing and biological assay results should include error bars, p-values, and measures of significance.

9. The bio-reduction process needs deeper exploration, linking phytochemicals and functional groups identified in FTIR to biological activities.

10. Implications like scalability, toxicity, and economic feasibility of Asplenium dalhousiae-based AgNPs are not well addressed by the authors.

11. Redundancy is evident, with repeated discussions on green synthesis of AgNPs’ and its biomedical roles without adding new insights.

12. Oversimplified statements such as “Nanoparticles are far more dangerous to cancerous cells than bulk materials,” these statements show lack of explanation with supporting references.

13. The antioxidant assay concentration range (10–100 µg/ml) is vague and lacks justification linked to standard protocols with particular reference.

14. Broad peaks in XRD patterns require consideration of factors like crystallanity and particle size distribution with particular strain during interpretation.

15. Missing details, such as solvent partition criteria and centrifugation rationale, hindered reproducibility.

16. The reported particle size range in SEM is of 1–100 nm is excessively broad and should include specific details like average size, standard deviation, and size distribution.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Krishnan Raguvaran

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-42400_reviewer.pdf

pone.0325533.s007.pdf (5.5MB, pdf)
Attachment

Submitted filename: PONE-D-24-42400-Reviewer Comments-V1.docx

pone.0325533.s008.docx (14.6KB, docx)
PLoS One. 2025 Jun 30;20(6):e0325533. doi: 10.1371/journal.pone.0325533.r002

Author response to Decision Letter 1


14 Feb 2025

PONE-D-24-42400

Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties

PLOS ONE

Reviewer #1:

The effects of the AgNPs using Asplenium dalhousiae on their antibacterial, antioxidant, α-amylase inhibitory and cytotoxic activities.

General comments,

Comments Response

1. The manuscript's structure is poorly organized; the author should revise it.

I appreciate your comment regarding the manuscript's structure. I will carefully revise and reorganize the content to improve its clarity and flow, ensuring that the manuscript is more coherent and well-structured."

2. The author should maintain the same font throughout the manuscript. Thank you for the feedback; I have ensured that the font is consistent throughout the manuscript.

3. The author should compare their results with previous studies to provide context and validate their findings. Additionally, the discussion section needs improvement to offer a more comprehensive analysis and interpretation of the results. Thank you for your suggestions. I will revise the discussion section to include comparisons with previous studies and provide a more detailed analysis and interpretation of the results.

4. For the antibacterial activity, it is insufficient for the author to work with a single concentration, as this does not provide a comprehensive assessment of the antibacterial properties. Multiple concentrations should be tested to better evaluate the activity.

Thank you very much for your insightful comment. We fully understand the importance of testing multiple concentrations to provide a comprehensive assessment of antibacterial activity. In this study, we chose to evaluate the antibacterial properties at a single concentration of 30 µg/ml due to practical constraints. This concentration was selected based on preliminary experiments that indicated significant antimicrobial activity across the different extracts and AgNPs. Additionally, different plant extracts, including those from CHCl3, aqueous, and n-hexane layers, were used to represent compounds of varying polarities. The choice of 30 µg/ml was intended to provide a consistent basis for comparing the activity of compounds with distinct polarity profiles.

We agree that evaluating antibacterial activity at multiple concentrations would offer a more thorough understanding of the dose-dependent effects. We intend to explore this in future studies when additional resources allow for a more detailed investigation into concentration-dependent activity. We appreciate your feedback and hope to address this aspect in our forthcoming research.

5. The author has presented their results in Figures 1, 2, 3, etc., without citing the figure numbers in the text. The author should properly cite the figure numbers in accordance with the corresponding results for better clarity and alignment We have carefully incorporated the suggested revisions into the manuscript, and all figures have been appropriately cited within the text.

6. More detailed table and figure captions should be given for self-understood.

Thank you for highlighting the need for more detailed captions for tables and figures. We have carefully revised all captions to make them more descriptive and self-explanatory. The updated captions now provide additional context, including details about the experimental setup, variables, units, and key observations, ensuring clarity for the reader without requiring reference to the main text. We believe these changes enhance the comprehensibility of the data presented."

7. The resolution of the characterization figures for the AgNPs needs to be improved to enhance clarity and allow for better interpretation of the results.

Thank you for your insightful comment regarding the resolution of the characterization figures for the AgNPs. We have revisited the figures and improved their resolution to enhance clarity and ensure that all details are visible and interpretable. The revised figures have been exported in high-resolution formats (300 DPI) to meet publication standards. We trust that the updated images now provide better visual quality for accurate interpretation of the results."

8. Table 3, the author should include the standard deviation (SD) value for each AgNPs and ascorbic acid in the same column, rather than in a separate column

We have revised the table to combine the '% Cell Viability' and corresponding Standard Deviation (SD) values into a single column for both AgNPs and Ascorbic Acid, as suggested.

9. In Table 4, it is unclear why the author has provided a 'groups' column for the concentration. This should be clarified or revised for better understanding. And delete the empty box in the table.

Thank you for your valuable comment regarding the 'Groups' column in Table 4. After considering your feedback, we have removed the 'Groups' column to eliminate any confusion. The table now presents the concentrations directly in the first column, making it clearer and more straightforward. Additionally, we have deleted the empty box as suggested. We believe this revision improves the presentation and readability of the data.

10. In Table 5, instead of 'Active,' the author should mention the value of the IC50.

Detailed comments have been noted on the manuscript.

Suggestion has been in corporate

Reviewer #2: Manuscript ID: PONE-D-24-42400

Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties

S No. Comments Response

1. The English language and grammar in the whole manuscript needs further improvement, particularly in sections such as Introduction, Materials and Methods. We will thoroughly review the manuscript and make the necessary improvements to the English language and grammar, particularly in the Introduction and Materials and Methods sections, to ensure clarity and readability

2. The statements such as “paving the way for improved treatment outcomes in patients with ovarian cancer” mentioned in the end of the Abstract are speculative without preclinical or clinical validation. Cytotoxicity is an in-vitro property that does not equate with the therapeutic efficacy for in-vivo and should be compared with literature to substantiate differences.

We will revise the Abstract to clearly indicate that the findings are based on in-vitro studies and emphasize the need for further preclinical and clinical investigations. Additionally, we will compare our cytotoxicity results with relevant literature to provide context and highlight any significant differences."

3. Figures are poorly presented and should be arranged into collages for better readability and interpretation.

We will reorganize the figures into well-structured collages to enhance their readability and facilitate better interpretation. The revised figures will be designed to ensure clarity and improve the overall presentation of the data

4. The study lacks mechanistic insights, such as identifying specific compounds in Asplenium dalhousiae responsible for nanoparticle synthesis and their specific role in reduction and stabilization.

Thank you for your valuable suggestion. We acknowledge the importance of providing mechanistic insights. While this study focuses on demonstrating the synthesis and biological activities of nanoparticles, future work will aim to identify the specific compounds in Asplenium dalhousiae responsible for nanoparticle synthesis and elucidate their role in reduction and stabilization. We will also include a discussion in the manuscript to address this limitation and highlight the need for further investigation

5. The α-amylase inhibition and cytotoxic mechanisms are not explained well by authors.

Thank you for your valuable feedback. We acknowledge the need for a more detailed explanation of the α-amylase inhibition and cytotoxic mechanisms. We have added the mechanism in the revised manuscript,

6. The authors claim in the introduction section that the reported work is the "first comprehensive investigation" of Asplenium dalhousiae which is unsupported with the previously published and related research. Comparison with other studies on plant-mediated AgNP synthesis is required to highlight the novelty.

We have revised the introduction to acknowledge prior studies on plant-mediated AgNP synthesis and added comparisons with related research to highlight the novelty of using Asplenium dalhousiae for the first time in this context.

7. Characterization methods such as UV-Vis, FTIR, XRD, and SEM are discussed generally, without any specific experimental optimization or justifications, that could be associated with the changes made before and after synthesis in the results obtained through these characterizations.

We have updated the manuscript to include specific details on the experimental optimizations and justifications for using UV-Vis, FTIR, XRD, and SEM methods. Additionally, we have elaborated on the observed changes before and after synthesis, linking them to the results obtained from these characterizations.

8. Statistical analysis is missing and biological assay results should include error bars, p-values, and measures of significance.

We have included statistical analysis in the revised manuscript, incorporating error bars, p-values, and measures of significance for the biological assay results to ensure accurate interpretation and validation of the data.

9. The bio-reduction process needs deeper exploration, linking phytochemicals and functional groups identified in FTIR to biological activities. We have expanded the discussion on the bio-reduction process by linking the phytochemicals and functional groups identified in FTIR to their potential roles in the reduction and stabilization of AgNPs, as well as their contribution to the observed biological activities.

10. Implications like scalability, toxicity, and economic feasibility of Asplenium dalhousiae-based AgNPs are not well addressed by the authors. The scalability of Asplenium dalhousiae-based AgNPs production is achievable due to the abundance of the plant material and the simplicity of the green synthesis method, which avoids the use of expensive or hazardous chemicals. In terms of toxicity, the biocompatibility of the plant-derived nanoparticles has been discussed in the context of their reduced environmental impact and selective bioactivity, supported by their antioxidant and antibacterial properties. Additionally, the economic feasibility is highlighted by the low-cost extraction process and the use of renewable plant resources, making it a sustainable and cost-efficient alternative for nanoparticle synthesis. These aspects emphasize the practical advantages and potential for commercial application of the reported method.

11. Redundancy is evident, with repeated discussions on green synthesis of AgNPs’ and its biomedical roles without adding new insights.

We acknowledge the comment regarding redundancy in the discussion of green synthesis and biomedical roles of AgNPs. To address this, we have carefully revised the manuscript by consolidating repetitive content and emphasizing unique aspects of our study, such as the distinct contribution of Asplenium dalhousiae phytochemicals in nanoparticle synthesis and their specific biological activities. This revision ensures clarity and avoids unnecessary repetition.

12. Oversimplified statements such as “Nanoparticles are far more dangerous to cancerous cells than bulk materials,” these statements show lack of explanation with supporting references.

I agree that the statement lacks sufficient explanation and supporting references. The enhanced efficacy of nanoparticles over bulk materials, particularly in the context of cancer treatment, can be attributed to their unique physicochemical properties such as a high surface area-to-volume ratio, the ability to penetrate biological barriers, and targeted drug delivery. I will revise the statement to include these details and references to provide a more thorough explanation.

13. The antioxidant assay concentration range (10–100 µg/ml) is vague and lacks justification linked to standard protocols with particular reference.

14. Broad peaks in XRD patterns require consideration of factors like crystallanity and particle size distribution with particular strain during interpretation.

15. Missing details, such as solvent partition criteria and centrifugation rationale, hindered reproducibility.

16. The reported particle size range in SEM is of 1–100 nm is excessively broad and should include specific details like average size, standard deviation, and size distribution.

Attachment

Submitted filename: Comments paper highlighted comments.docx

pone.0325533.s011.docx (20.5KB, docx)

Decision Letter 1

Chinnaperumal Kamaraj

Dear Dr. maher,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Dear Dr. Saima Maher,

Thank you for submitting your manuscript titled "Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties" to PLOS ONE. After a comprehensive review, we are happy to inform you that your manuscript is nearly ready for acceptance. However, in light of the reviewer feedback, a few minor revisions are necessary before we can proceed with finalizing the publication.

==============================

Please submit your revised manuscript by May 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Chinnaperumal Kamaraj, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Saima Maher,

Thank you for submitting your manuscript titled "Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties" to PLOS ONE. After a comprehensive review, we are happy to inform you that your manuscript is nearly ready for acceptance. However, in light of the reviewer's feedback, a few minor revisions are necessary before we can proceed with finalizing the publication.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #3: Yes

**********

Reviewer #1: This study prepared silver nanoparticles (Ag-NPs) synthesized using Asplenium dalhousiae, which demonstrated significant antibacterial, antioxidant, α-amylase inhibitory, and anticancer activity. However, there is still room for improvement in writing quality, graphical representation, and the overall content of the manuscript. Therefore, I believe this manuscript is acceptable for publication in PLOS ONE after minor revisions.

1. In the abstract, the author initially mentioned that antibacterial activity was tested against Bacillus subtilis and Escherichia coli. However, this information does not match the results section. The author should ensure consistency and correct this based on the original experiment.

2. The author should clarify whether plant extracts (aqueous, chloroform, and n-hexane) were obtained through natural dissolution and provide a more detailed explanation of the extraction process using different solvents.

3. The UV-Vis spectroscopy section should be rewritten separately, with some portions moved to the Results and Discussion section.

4. Additionally, the author should provide details of the instruments used, including the make and manufacturer, for all technical analyses.

5. The manuscript contains several typographical errors (e.g., punctuation mistakes in periods, commas, superscripts, and subscripts) and grammatical issues. These should be corrected, and the author should ensure a smooth flow of sentences.

6. Preparation of Asplenium dalhousiae Extract and AgNPs: The term "AgNPs water" is unclear and should be clarified.

7. The methodology for the preparation of Asplenium dalhousiae extract and AgNPs synthesis is confusing and should be revised for better clarity.

8. The Statistical Analysis section should be placed at the end of the Methods section.

9. Some words in the manuscript are bolded without a clear reason. The author should clarify if there is a specific purpose for this formatting.

10. During AgNP synthesis, the observed color change is inconsistent. Some sections describe a transition from colorless to reddish-brown, while others mention yellow to orange-brown. The author should carefully revise the manuscript to ensure consistency in experimental results and methods.

11. Figure 3 (FTIR Spectrum of Asplenium dalhousiae Plant Extract): The legend describes FTIR analysis of aqueous, chloroform, and n-hexane extracts. If the results refer to AgNPs rather than plant extracts, the legend should be revised accordingly.

12. Figure 4 (XRD Analysis of AgNPs): The author should maintain consistency in terminology when referring to plant extracts or layers.

13. The figure and legend should be revised for uniformity.

14. Table 1 (Antibacterial Activity of Silver Nanoparticles and Plant Extracts): The mean values and dose figures should be formatted uniformly.

15. The author should verify whether Figure 7 represents the antidiabetic test results.

16. All figure legends should be revised, as they do not accurately describe the graphical data. The author is requested to use appropriate legends for each test result.

Reviewer #3: Author did a excellent job in nanomaterials and biomedical application. The author has addressed all comments. Now accepted to publication

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Attachment

Submitted filename: Comments.docx

pone.0325533.s010.docx (20.5KB, docx)
PLoS One. 2025 Jun 30;20(6):e0325533. doi: 10.1371/journal.pone.0325533.r004

Author response to Decision Letter 2


1 May 2025

Dear Chinnaperumal Kamaraj, Ph.D Date: 22/04/2025

Editor

PLOS ONE

Subject: Resubmission of Manuscript (PONE-D-24-42400R1)

Dear Dr. Kamaraj,

Thank you for the opportunity to revise and resubmit our manuscript titled "Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties" (PONE-D-24-42400R1). We greatly appreciate the feedback from both you and the reviewers, which has been extremely helpful in improving the quality of the manuscript. We have carefully addressed all the comments raised, as outlined below.

Reviewer #1:

1. Comment: In the abstract, the author initially mentioned that antibacterial activity was tested against Bacillus subtilis and Escherichia coli. However, this information does not match the results section. The author should ensure consistency and correct this based on the original experiment.

Response: Thank you for highlighting this discrepancy. We have carefully reviewed the manuscript and ensured that the antibacterial activity results are consistent across the abstract and results sections. The correct bacterial strains tested are now consistently mentioned as Bacillus subtilis and Escherichia coli.

2. Comment: The author should clarify whether plant extracts (aqueous, chloroform, and n-hexane) were obtained through natural dissolution and provide a more detailed explanation of the extraction process using different solvents.

Response: We have revised the Materials and Methods section to clarify the extraction process of the plant material. We now provide a more detailed explanation of the solvent extraction procedure, specifying the methods used for aqueous, chloroform, and n-hexane extracts.

3. Comment: The UV-Vis spectroscopy section should be rewritten separately, with some portions moved to the Results and Discussion section.

Response: We have revised the manuscript as requested. The UV-Vis spectroscopy section has been separated and rewritten with a focus on the results and discussion of the data in the Results and Discussion section. The experimental details have been moved to the Materials and Methods section.

4. Comment: The author should provide details of the instruments used, including the make and manufacturer, for all technical analyses.

Response: We have updated the manuscript to include detailed information about the instruments used for each technical analysis, including the make and manufacturer, as suggested.

5. Comment: The manuscript contains several typographical errors (e.g., punctuation mistakes in periods, commas, superscripts, and subscripts) and grammatical issues. These should be corrected, and the author should ensure a smooth flow of sentences.

Response: We appreciate this observation. We have thoroughly proofread the manuscript to correct typographical and grammatical errors, including issues with punctuation, superscripts, and subscripts. The flow of sentences has also been improved for better readability.

6. Comment: The term “AgNPs water” is unclear and should be clarified.

Response: The term “AgNPs water” has been revised for clarity. We now refer to it as “aqueous dispersion of AgNPs” throughout the manuscript to avoid any confusion.

7. Comment: The methodology for the preparation of Asplenium dalhousiae extract and AgNPs synthesis is confusing and should be revised for better clarity.

Response: We have revised the Materials and Methods section to clarify the synthesis of AgNPs from Asplenium dalhousiae extracts. The revised description now provides a clearer step-by-step process for both the plant extract preparation and nanoparticle synthesis.

8. Comment: The Statistical Analysis section should be placed at the end of the Methods section.

Response: We have moved the Statistical Analysis section to the end of the Materials and Methods section, as suggested, to align with the manuscript’s structure.

9. Comment: Some words in the manuscript are bolded without a clear reason. The author should clarify if there is a specific purpose for this formatting.

Response: We have reviewed the manuscript and removed unnecessary bolding. Any remaining bolded words now serve a clear purpose for emphasis or as part of section headings.

10. Comment: During AgNP synthesis, the observed color change is inconsistent. Some sections describe a transition from colorless to reddish-brown, while others mention yellow to orange-brown. The author should carefully revise the manuscript to ensure consistency in experimental results and methods.

Response: We have carefully reviewed and revised the description of the color change during AgNP synthesis. The manuscript now consistently describes the color change as “colorless to reddish-brown,” which aligns with the observed experimental results.

11. Comment: Figure 3 (FTIR Spectrum of Asplenium dalhousiae Plant Extract): The legend describes FTIR analysis of aqueous, chloroform, and n-hexane extracts. If the results refer to AgNPs rather than plant extracts, the legend should be revised accordingly.

Response: We have revised the legend of Figure 3 to clearly specify that the FTIR analysis was conducted on the Asplenium dalhousiae plant extracts. Any mention of AgNPs in the legend has been removed for accuracy.

12. Comment: Figure 4 (XRD Analysis of AgNPs): The author should maintain consistency in terminology when referring to plant extracts or layers.

Response: We have ensured consistency in terminology in the Results and Figures sections. We now consistently refer to the AgNPs and plant extracts separately, with clear distinctions between the two.

13. Comment: The figure and legend should be revised for uniformity.

Response: We have revised the figures and their legends to ensure uniformity in presentation. All figure formatting and legends now follow the same structure for consistency.

14. Comment: Table 1 (Antibacterial Activity of Silver Nanoparticles and Plant Extracts): The mean values and dose figures should be formatted uniformly.

Response: We have updated Table 1 to ensure uniform formatting of the mean values and dose figures, ensuring consistency throughout the manuscript.

15. Comment: The author should verify whether Figure 7 represents the antidiabetic test results.

Response: We have reviewed Figure 7, and we confirm that it represents the anti-diabetic test results. The legend has been updated to ensure that it accurately reflects this data.

16. Comment: All figure legends should be revised, as they do not accurately describe the graphical data. The author is requested to use appropriate legends for each test result.

Response: We have carefully revised all figure legends to ensure they accurately describe the graphical data. Each legend now clearly corresponds to the respective test results (e.g., antibacterial, antioxidant, anti-diabetic activities).

We sincerely appreciate the valuable comments from the reviewers, which have significantly improved the manuscript. We believe that the revisions have addressed all concerns raised, and we are confident that the revised manuscript is now suitable for publication. We look forward to your favorable consideration of our revised submission.

Thank you once again for your time and consideration.

Sincerely,

Dr. Saima Mehar

SBK Women University

Attachment

Submitted filename: response to reviewer.docx

pone.0325533.s012.docx (16.8KB, docx)

Decision Letter 2

Chinnaperumal Kamaraj

Biosynthesis and Characterization of Silver Nanoparticles from Asplenium dalhousiae and their Potential Biological Properties

PONE-D-24-42400R2

Dear Dr. maher,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chinnaperumal Kamaraj, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Chinnaperumal Kamaraj

PONE-D-24-42400R2

PLOS ONE

Dear Dr. maher,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chinnaperumal Kamaraj

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Graphical abstract.

    (TIF)

    pone.0325533.s001.tif (787.5KB, tif)
    S2 Fig. Asplenium dalhousiae.

    (TIF)

    pone.0325533.s002.tif (1.7MB, tif)
    S3 Fig. Graphical representation of the anticancer activity.

    (TIF)

    pone.0325533.s003.tif (262KB, tif)
    S1 Table. Antibacterial activity of silver nanoparticles and plant extracts against selected bacterial raw data file.

    (TIF)

    pone.0325533.s004.tif (354.2KB, tif)
    S2 Table. DPPH Radical scavenging capacity of ascorbic acid and (AgNPs).

    (TIF)

    pone.0325533.s005.tif (196.4KB, tif)
    S3 Table. Inhibition of in-vitro α-amylase enzyme assay raw data file.

    (TIF)

    pone.0325533.s006.tif (262KB, tif)
    Attachment

    Submitted filename: PONE-D-24-42400_reviewer.pdf

    pone.0325533.s007.pdf (5.5MB, pdf)
    Attachment

    Submitted filename: PONE-D-24-42400-Reviewer Comments-V1.docx

    pone.0325533.s008.docx (14.6KB, docx)
    Attachment

    Submitted filename: Comments paper highlighted comments.docx

    pone.0325533.s011.docx (20.5KB, docx)
    Attachment

    Submitted filename: Comments.docx

    pone.0325533.s010.docx (20.5KB, docx)
    Attachment

    Submitted filename: response to reviewer.docx

    pone.0325533.s012.docx (16.8KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES